Sanofi Insmed Acquisition Talk: What a Bid for the Brinsupri Maker Would Mean
Sanofi is weighing a takeover of Insmed, maker of bronchiectasis drug Brinsupri, Bloomberg reported. Insmed rose about 16% from a $26.3B value. Here is what is known.
Sanofi is weighing a takeover of Insmed, maker of bronchiectasis drug Brinsupri, Bloomberg reported. Insmed rose about 16% from a $26.3B value. Here is what is known.